Durability of Bivalent Boosters against Omicron Subvariants

Durability of Bivalent Boosters against Omicron Subvariants

In a trial of two bivalent Covid-19 boosters, effectiveness against severe infection resulting in hospitalization or death reached a level of 67.4% after 2 weeks and decreased to 38.4% after 20 weeks.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2023-05, Vol.388 (19), p.1818-1820
Hauptverfasser: Lin, Dan-Yu, Xu, Yangjianchen, Gu, Yu, Zeng, Donglin, Sunny, Shadia K., Moore, Zack
Format: Artikel
Sprache:eng
Schlagworte:
Clinical outcomes
Coronavirus
Coronaviruses
Correspondence
COVID-19
COVID-19 vaccines
Hospitalization
Infections
Infectious Disease
Severe acute respiratory syndrome coronavirus 2
Vaccines
Viral Infections
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In a trial of two bivalent Covid-19 boosters, effectiveness against severe infection resulting in hospitalization or death reached a level of 67.4% after 2 weeks and decreased to 38.4% after 20 weeks.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMc2302462